Loading IPO Details...
Upcoming IPOs
Pharmaceuticals · Listed on BSE , NSE · 24 Mar 2026 - 27 Mar 2026
Jagat JoshiSai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.
Its medicines are available in various forms like tablets, injections, and syrups. Sai Parenteral’s major clients are government agencies, pharmaceutical companies, public and private hospitals, and large distributors in India. The firm operates 5 manufacturing facilities in India, mainly located in Hyderabad, known for developing medicines with international quality certifications.
| Date & Time | GMP (₹) | Est. Listing Price | Est. Gain (%) | Est. Profit / Lot (₹) |
|---|---|---|---|---|
| 02-Apr-2026 02:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 01-Apr-2026 02:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 31-Mar-2026 02:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 30-Mar-2026 02:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 29-Mar-2026 02:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 28-Mar-2026 02:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 27-Mar-2026 02:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 26-Mar-2026 02:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 25-Mar-2026 01:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 24-Mar-2026 01:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 23-Mar-2026 01:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 21-Mar-2026 01:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 20-Mar-2026 01:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 19-Mar-2026 01:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 18-Mar-2026 01:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| 17-Mar-2026 01:00 PM | +₹0 | ₹392 | +0.00% | ₹0 |
| Category | Subscription (x) | Shares Offered | Shares bid for | Total Amount (₹ Cr) |
|---|---|---|---|---|
| QIB (Ex. Anchor) | 1.73x | 20,85,658 | 36,10,266 | ₹141.52 Cr |
| NII | 2.45x | 15,64,244 | 38,31,502 | ₹150.19 Cr |
| bNII > ₹10L | 3.56x | 10,42,829 | 37,07,318 | ₹145.33 Cr |
| sNII < ₹10L | 0.24x | 5,21,415 | 1,24,184 | ₹4.87 Cr |
| Retail | 0.12x | 36,49,901 | 4,39,204 | ₹17.22 Cr |
| Total | 1.08x | 72,99,803 | 78,80,972 | ₹308.93 Cr |
| Period Ended | 30 SEPT 2025 | 31 MAR 2025 | 31 MAR 2024 |
|---|---|---|---|
| Total Income | 89.43 | 163.74 | 155.18 |
| Profit After Tax | 7.76 | 14.43 | 8.42 |
| EBITDA | 16.24 | 39.44 | 31.70 |
| NET Worth | 209.37 | 95.78 | 76.40 |
| Reserves and Surplus | 188.84 | 80.36 | 61.30 |
| Total Borrowing | 76.07 | 93.95 | 118.79 |
| Company Name | EPS (₹) | P/E (x) | NAV (₹) | RoNW (%) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Industry Average | - | 62.29 | - | - | - |
| Gland Pharma Limited | 42.40 | 44.71 | 555.41 | 7.63 | 5,616.50 |
| Senores Pharmaceuticals Limited | 16.12 | 64.30 | 176.37 | 7.18 | 398.25 |
| Innova Captab Limited | 22.41 | 32.45 | 167.66 | 13.37 | 1,243.68 |
| Sai Life Sciences Limited | 8.83 | 107.70 | 102.12 | 7.99 | 1,694.57 |
Anil Kumar Karusala, Vijitha Gorrepati, Karusala Aruna are the company's promoters of Sai Parenteral's Ltd..
| Particular | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 61.23% | 51.16% |
| Others* | 38.77% | 48.84% |
Join the discussion
Please sign in to leave a comment or reply.